Global Female Emergency Contraceptive Pill Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Female Emergency Contraceptive Pill market size will reach 632.09 Million USD in 2025 and is projected to reach 802.56 Million USD by 2032, with a CAGR of 3.47% (2025-2032). Notably, the China Female Emergency Contraceptive Pill market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

A female emergency contraceptive pill, often referred to as the ＂morning-after pill,＂ is a medication designed to prevent pregnancy when taken shortly after unprotected sexual intercourse or contraceptive failure. It typically contains hormones such as levonorgestrel or ulipristal acetate and works by either inhibiting or delaying ovulation, preventing fertilization of an egg, or altering the uterine lining to inhibit implantation of a fertilized egg. Emergency contraceptive pills are not intended for regular contraception but serve as a backup option when other forms of contraception fail or are not used. They should be taken as soon as possible after unprotected sex, ideally within 72 hours, although some formulations may be effective for up to five days afterward. These pills are available over-the-counter in many countries and can be a valuable tool for women to prevent unintended pregnancies.

The major global  manufacturers of Female Emergency Contraceptive Pill include Foundation Consumer Healthcare, Gedeon Richter, Zizhu Pharma, Zhejiang Xianju Pharma, HRA Pharma, Regenex, Mankind Pharma, Piramal, Lupin, Syzygy Healthcare, HLL Life Care, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Female Emergency Contraceptive Pill. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Female Emergency Contraceptive Pill market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Female Emergency Contraceptive Pill market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Female Emergency Contraceptive Pill industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Female Emergency Contraceptive Pill Include:

Foundation Consumer Healthcare

Gedeon Richter

Zizhu Pharma

Zhejiang Xianju Pharma

HRA Pharma

Regenex

Mankind Pharma

Piramal

Lupin

Syzygy Healthcare

HLL Life Care

Female Emergency Contraceptive Pill Product Segment Include:

Levonorgestrel

Ulipristal Acetate

Female Emergency Contraceptive Pill Product Application Include:

Online Sales

Offline Sales

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Female Emergency Contraceptive Pill Industry PESTEL Analysis

Chapter 3: Global Female Emergency Contraceptive Pill Industry Porter's Five Forces Analysis

Chapter 4: Global Female Emergency Contraceptive Pill Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Female Emergency Contraceptive Pill Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Female Emergency Contraceptive Pill Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Female Emergency Contraceptive Pill Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more